Biogen strongly believes that collaboration with healthcare professionals is crucial to discover, develop and deliver innovative therapies that improve the lives of patients. At the same time, we believe that these interactions must be conducted openly and transparently.

As a member of EFPIA (the European Federation of Pharmaceutical Industries and Associations), Biogen is proud to endorse and uphold the EFPIA Disclosure Code. In line with the code, Biogen has been collecting all payments and contributions made to Healthcare Professionals and Organizations since January 2015.

These will be published in June 2016 or in accordance with the requirements of each local association/law.

Biogen International GmbH is committed to working with patient organizations and supporting their efforts to improve the lives of their members and raise awareness of serious medical conditions. We are aligned in enhancing patient advocacy and supporting medical research for the discovery of effective therapies with a focus on neurological, autoimmune and hematologic disorders.

In 2014, Biogen International provided funding to the patient organizations below in support of several important projects.

Patient organization Project Amount of support
European Federation of Neurological Associations Funding to support project platform and Patient Experience Survey 30 000 EUR
European MS Platform, EMSP European MS Platform, EMSP 190 000 EUR
European Patients' Forum Training on Fundraising for EPF European Members 20 000 EUR
EURORDIS Rare Connect 40 000 EUR
International MS Federation, MSIF Building stronger MS organizations in the Middle East and World MS Day 2014 75 000 GBP